Kim Y, Lee S
Front Oncol. 2024; 14:1487467.
PMID: 39629000
PMC: 11611718.
DOI: 10.3389/fonc.2024.1487467.
Hashimoto T, Nakamura Y, Komatsu Y, Yuki S, Takahashi N, Okano N
BJC Rep. 2024; 2(1):54.
PMID: 39516322
PMC: 11523999.
DOI: 10.1038/s44276-024-00073-7.
Arita A, Takahashi T, Nakajima K, Kurokawa Y, Hirota S, Nishida T
Surg Case Rep. 2023; 9(1):183.
PMID: 37870660
PMC: 10593636.
DOI: 10.1186/s40792-023-01766-w.
Rahimi-Ardabily A, Murdande S, Dong M, Gu K, Zhang B, Miller K
Langenbecks Arch Surg. 2023; 408(1):373.
PMID: 37740754
DOI: 10.1007/s00423-023-03052-7.
Incorvaia L, de Biase D, Nannini M, Fumagalli E, Vincenzi B, De Luca I
Oncologist. 2023; 29(1):e141-e151.
PMID: 37463014
PMC: 10769785.
DOI: 10.1093/oncolo/oyad206.
Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers.
Li B, Chen H, Yang S, Chen F, Xu L, Li Y
Mol Cancer. 2023; 22(1):71.
PMID: 37072770
PMC: 10111719.
DOI: 10.1186/s12943-023-01770-6.
Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors.
Masucci M, Motti M, Minopoli M, Di Carluccio G, Carriero M
Int J Mol Sci. 2023; 24(7).
PMID: 37046997
PMC: 10094678.
DOI: 10.3390/ijms24076026.
Characterization of cell line with dedifferentiated GIST-like features established from cecal GIST of familial GIST model mice.
Sano D, Kihara T, Yuan J, Kimura N, Ohkouchi M, Hashikura Y
Pathol Int. 2023; 73(5):181-187.
PMID: 36825754
PMC: 11551817.
DOI: 10.1111/pin.13315.
Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review.
Ge Q, Liu Y, Yang F, Sun G, Guo J, Sun S
Int J Mol Sci. 2023; 24(1).
PMID: 36614290
PMC: 9820900.
DOI: 10.3390/ijms24010830.
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations.
Mandelker D, Marra A, Mehta N, Selenica P, Yelskaya Z, Yang C
NPJ Precis Oncol. 2023; 7(1):1.
PMID: 36593350
PMC: 9807588.
DOI: 10.1038/s41698-022-00342-z.
Current Molecular Profile of Gastrointestinal Stromal Tumors and Systemic Therapeutic Implications.
Mathias-Machado M, de Jesus V, Oliveira L, Neumann M, Peixoto R
Cancers (Basel). 2022; 14(21).
PMID: 36358751
PMC: 9656487.
DOI: 10.3390/cancers14215330.
Familial gastrointestinal stromal tumors with germline mutation in a Chinese family: A case report.
Yuan W, Huang W, Ren L, Xu C, Luan L, Huang J
World J Clin Cases. 2022; 10(15):4878-4885.
PMID: 35801023
PMC: 9198863.
DOI: 10.12998/wjcc.v10.i15.4878.
Extra gastrointestinal stromal tumor EGIST in the recto-vesical pouch: A case report and literature review.
Harouachi A, Harhar M, Mhand M, Atmani A, Elamrani A, Kharkhach A
Ann Med Surg (Lond). 2022; 74:103283.
PMID: 35127068
PMC: 8807970.
DOI: 10.1016/j.amsu.2022.103283.
Recent Progress and Challenges in the Diagnosis and Treatment of Gastrointestinal Stromal Tumors.
Nishida T, Yoshinaga S, Takahashi T, Naito Y
Cancers (Basel). 2021; 13(13).
PMID: 34202544
PMC: 8268322.
DOI: 10.3390/cancers13133158.
Gastrointestinal stromal tumours.
Blay J, Kang Y, Nishida T, von Mehren M
Nat Rev Dis Primers. 2021; 7(1):22.
PMID: 33737510
DOI: 10.1038/s41572-021-00254-5.
Gastrointestinal Stromal Tumor in Monozygotic Twins Shows Distinct Mutational Status: A Case Report.
Sobral-Leite M, da Silva J, Pimenta-Inada H, Mendes Boisson A, Romeiro P, Soares Parago F
Am J Case Rep. 2021; 22:e929887.
PMID: 33674549
PMC: 7949489.
DOI: 10.12659/AJCR.929887.
Update on Molecular Genetics of Gastrointestinal Stromal Tumors.
Brcic I, Argyropoulos A, Liegl-Atzwanger B
Diagnostics (Basel). 2021; 11(2).
PMID: 33525726
PMC: 7912114.
DOI: 10.3390/diagnostics11020194.
A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity.
Fornasarig M, Gasparotto D, Foltran L, Campigotto M, Lombardi S, Del Savio E
J Pers Med. 2020; 10(4).
PMID: 33212994
PMC: 7711910.
DOI: 10.3390/jpm10040234.
Recent advances in the management of gastrointestinal stromal tumor.
Ahmed M
World J Clin Cases. 2020; 8(15):3142-3155.
PMID: 32874969
PMC: 7441252.
DOI: 10.12998/wjcc.v8.i15.3142.
LIX1 regulates YAP activity and controls gastrointestinal cancer cell plasticity.
Guerin A, Martire D, Trenquier E, Lesluyes T, Sagnol S, Pratlong M
J Cell Mol Med. 2020; 24(16):9244-9254.
PMID: 32633461
PMC: 7417687.
DOI: 10.1111/jcmm.15569.